Full Author : ['Gerstein, Hertzel C', 'Colhoun, Helen M', 'Dagenais, Gilles R', 'Diaz, Rafael', 'Lakshmanan, Mark', 'Pais, Prem', 'Probstfield, Jeffrey', 'Riesmeyer, Jeffrey S', 'Riddle, Matthew C', 'Ryden, Lars', 'Xavier, Denis', 'Atisso, Charles Messan', 'Dyal, Leanne', 'Hall, Stephanie', 'Rao-Melacini, Purnima', 'Wong, Gloria', 'Avezum, Alvaro', 'Basile, Jan', 'Chung, Namsik', 'Conget, Ignacio', 'Cushman, William C', 'Franek, Edward', 'Hancu, Nicolae', 'Hanefeld, Markolf', 'Holt, Shaun', 'Jansky, Petr', 'Keltai, Matyas', 'Lanas, Fernando', 'Leiter, Lawrence A', 'Lopez-Jaramillo, Patricio', 'Cardona Munoz, Ernesto German', 'Pirags, Valdis', 'Pogosova, Nana', 'Raubenheimer, Peter J', 'Shaw, Jonathan E', 'Sheu, Wayne H-H', 'Temelkova-Kurktschiev, Theodora']
Journal Title : Lancet (London, England)
Chapter : Section3
Journal Year : 2019
Cited by : Not Available
BACKGROUND: Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high glycated haemoglobin A(1c) (HbA(1c)) concentrations. We assessed the effect o.....
